Q32 Bio Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Q32 Bio Inc. reported Cash And Cash Equivalents At Carrying Value of $48.30 million for the year ending 2025.

  • Q32 Bio Inc. showed a decrease of -38.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Q32 Bio Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), Q32 Bio Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 324.0%.
  • Historical annual values: Fiscal year 2025: $48.30 million | Fiscal year 2024: $77.97 million | Fiscal year 2023: $25.62 million | Fiscal year 2022: $33.99 million | Fiscal year 2021: $108.38 million | Fiscal year 2020: $217.43 million | Fiscal year 2019: $53.77 million | Fiscal year 2018: $38.22 million | Fiscal year 2017: $51.58 million | Fiscal year 2016: $11.39 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: